These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27454416)

  • 21. Skin-Picking Disorder: A Guide to Diagnosis and Management.
    Jafferany M; Patel A
    CNS Drugs; 2019 Apr; 33(4):337-346. PubMed ID: 30877621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
    Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
    J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
    Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
    Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating obsessive compulsive disorder.
    Veale D
    Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
    [No Abstract]   [Full Text] [Related]  

  • 26. Obsessive-compulsive disorder.
    Veale D; Roberts A
    BMJ; 2014 Apr; 348():g2183. PubMed ID: 24709802
    [No Abstract]   [Full Text] [Related]  

  • 27. [Introduction to obsessive-compulsive disorder].
    Nakamura K; Ushijima S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):430-3. PubMed ID: 12877019
    [No Abstract]   [Full Text] [Related]  

  • 28. Special issue: Update on the nature and treatment of obsessive-compulsive-related disorders.
    Stanley M; Björgvinsson T; Frueh BC
    Bull Menninger Clin; 2010; 74(2):iii-vi. PubMed ID: 20545490
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of obsessive-compulsive disorder in children and adolescents.
    Boileau B
    Dialogues Clin Neurosci; 2011; 13(4):401-11. PubMed ID: 22275846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive-behavioral therapy for children who have obsessive-compulsive disorder.
    Piacentini J; Langley AK
    J Clin Psychol; 2004 Nov; 60(11):1181-94. PubMed ID: 15389618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbid tics have no effect on response to cognitive-behavioral therapy in youth with obsessive-compulsive disorder.
    Hanna GL
    Evid Based Ment Health; 2015 Aug; 18(3):85. PubMed ID: 26126872
    [No Abstract]   [Full Text] [Related]  

  • 33. [Obsessive-compulsive disorder in children and adolescents].
    Jans T; Walitza S; Warnke A
    Prax Kinderpsychol Kinderpsychiatr; 2008; 57(6):429-56. PubMed ID: 18800672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
    Kordon A; Broocks A; Hohagen F
    MMW Fortschr Med; 2003 May; 145 Suppl 2():4-7. PubMed ID: 14579475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
    Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
    Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Ginsburg GS; Kingery JN; Drake KL; Grados MA
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [To identify and treat obsessive-compulsive disorders: an overview].
    Voderholzer U; Hauer M; Stattrop U
    MMW Fortschr Med; 2013 Sep; 155(15):37-9. PubMed ID: 24224373
    [No Abstract]   [Full Text] [Related]  

  • 38. Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study.
    Jaurrieta N; Jimenez-Murcia S; Menchón JM; Del Pino Alonso M; Segalas C; Alvarez-Moya EM; Labad J; Granero R; Vallejo J
    Psychother Res; 2008 Sep; 18(5):604-14. PubMed ID: 18816010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Agid O; Lerer B
    J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.